Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Scleroderma in children

Y Uziel1, M L Miller, R M Laxer

  • 1Division of Rheumatology, Hospital for Sick Children, Toronto, Canada.

Pediatric Clinics of North America
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gathering expert consensus to inform a proposed trial in chronic nonbacterial osteomyelitis (CNO).

Clinical immunology (Orlando, Fla.)·2023
Same author

Erratum: Azimuthal Anisotropy of K_{S}^{0} and Λ+Λ[over ¯] Production at Midrapidity from Au+Au Collisions at sqrt[s]_{NN}=130  GeV [Phys. Rev. Lett. 89, 132301 (2002)].

Physical review letters·2021
Same author

Erratum: Azimuthal Anisotropy at the Relativistic Heavy Ion Collider: The First and Fourth Harmonics [Phys. Rev. Lett. 92, 062301 (2004)].

Physical review letters·2021
Same author

Short-term biological variation of serum thyroid hormones concentrations in clinically healthy cats.

Domestic animal endocrinology·2019
Same author

Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO.

PloS one·2019
Same author

Effect of Soil Solarization and Cover Crops on Populations of Selected Soilborne Plant Pathogens in Western Oregon.

Plant disease·2019
Same journal

Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

Pediatric clinics of North America·2026
Same journal

Advancing Pediatric Dermatology: Innovations in Care and Access.

Pediatric clinics of North America·2026
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
See all related articles

Childhood scleroderma encompasses diverse clinical forms, all marked by skin hardening. This review details their varied presentations, extracutaneous involvement, and discusses pathogenesis and treatment strategies.

Area of Science:

  • Pediatric Rheumatology
  • Dermatology
  • Autoimmune Diseases

Background:

  • Childhood scleroderma, or pediatric systemic sclerosis, presents with significant heterogeneity.
  • Skin hardening is a hallmark feature across all clinical subtypes.
  • Understanding these variations is crucial for accurate diagnosis and management.

Purpose of the Study:

  • To review the diverse clinical presentations of childhood scleroderma.
  • To highlight extracutaneous manifestations and clinical course differences.
  • To discuss current understanding of disease pathogenesis and treatment options.

Main Methods:

  • Comprehensive literature review of childhood scleroderma entities.
  • Focus on clinical features, including presentation and extracutaneous involvement.

Related Experiment Videos

  • Synthesis of current knowledge on pathogenesis and therapeutic approaches.

    • Main Results:

    • Childhood scleroderma exhibits varied clinical forms with distinct presentations.
    • Extracutaneous features and disease progression differ among subtypes.
    • The review consolidates key clinical characteristics for each entity.

    Conclusions:

    • Recognizing the heterogeneity of childhood scleroderma is essential for effective patient care.
    • Further research into pathogenesis may yield improved targeted therapies.
    • Tailored treatment strategies based on clinical presentation are recommended.